MiR-34b-5p inhibits cell proliferation, migration and invasion through targeting ARHGAP1 in breast cancer

被引:6
|
作者
Dong, Lifeng [1 ]
Chen, Fangfang [1 ]
Fan, Yangfan [1 ]
Long, Jingpei [1 ]
机构
[1] Zhejiang Univ, Womens Hosp, Dept Breast, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2020年 / 12卷 / 01期
关键词
microRNA-34b-5p; breast cancer; tumor growth; invasion; ARHGAP1; EPIGENETIC MODIFICATION; STATISTICS; EXPRESSION; MARKERS; KI67;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aim at investigating the function of microRNA (miR)-34b-5p in breast cancer prognosis and development. qRT-PCR was used for miR-34b-5p expression examination in breast cancer samples. CCK8, immunohistochemistry, scratch wound healing, transwell assays were performed for cell experiments. Subcutaneously implanted tumor model was carried out for animal experiment. Western blot was conducted for protein expression detection. Bioinformatics analysis was performed for exploring the underlying mechanism. MiR-34b-5p expression was down-regulated in breast cancer samples and cells, and miR-34d-5p could inhibit cell viability, migration and invasion also delay tumor growth in vivo. Low miR-34b-5p expression showed a bad prognosis of breast cancer patients. MiR-34b-5p functioned as a tumor suppressor by targeting ARHGAP1, and ARHGAP1 knockdown could reverse the effect of miR-34b-5p inhibitor on breast cancer cells. MiR-34b-5p exerts an anti-tumorigenesis role in breast cancer cells by targeting ARHGAP1, which is profitable for the breast cancer diagnosis and molecular treatment.
引用
收藏
页码:269 / 280
页数:12
相关论文
共 50 条
  • [21] MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2
    Wang, Li-Bing
    Feng, Liang
    He, Jing
    Liu, Bo
    Sun, Jian-Guang
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2019, 16 (06) : 6923 - 6933
  • [22] Downregulation of miR-362-5p inhibits proliferation, migration and invasion of human breast cancer MCF7 cells
    Ni, Fang
    Gui, Zhaohua
    Guo, Qiang
    Hu, Zhongqian
    Wang, Xinyi
    Chen, Danlei
    Wang, Siying
    ONCOLOGY LETTERS, 2016, 11 (02) : 1155 - 1160
  • [23] MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1
    Yu, Weixuan
    Li, Dongwei
    Zhang, Yunda
    Li, Cheukfai
    Zhang, Chuanzhao
    Wang, Libin
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2019, 18
  • [24] miR-149-5p inhibits cell proliferation and invasion through targeting GIT1 in medullary thyroid carcinoma
    Ye, Xiaojuan
    Chen, Xiaofang
    ONCOLOGY LETTERS, 2019, 17 (01) : 372 - 378
  • [25] Silencing of miR-200a-3p Inhibits Proliferation, Invasion and Migration of Breast Cancer Cells by Targeting Ephrin-A5
    Zhang, Yongmei
    Zhang, Huayi
    Guo, Gang
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2021, 11 (07) : 1227 - 1235
  • [26] MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1
    Zhu, Lin
    Chen, Yinan
    Nie, Kai
    Xiao, Yongxin
    Yu, Hong
    CANCER BIOMARKERS, 2018, 23 (02) : 301 - 309
  • [27] miR-31 inhibits cell proliferation and invasion through targeting ROCK1 in prostate cancer
    Zhang, Wenbin
    Zhou, Jin
    Wu, Wenfeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 2908 - 2916
  • [28] MicroRNA-100 inhibits breast cancer cell proliferation, invasion and migration by targeting FOXA1
    Xie, Haihui
    Xiao, Ruobing
    He, Yaolin
    He, Lingzhi
    Xie, Changjun
    Chen, Juan
    Hong, Yan
    ONCOLOGY LETTERS, 2021, 22 (06)
  • [29] miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1
    Li, Hongling
    Bian, Chunjing
    Liao, Lianming
    Li, Jing
    Zhao, Robert Chunhua
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (03) : 565 - 575
  • [30] MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2
    Li, Hesheng
    Sun, Qinglei
    Han, Bing
    Yu, Xingquan
    Hu, Baoguang
    Hu, Sanyuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 4782 - 4790